604 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Caesars Entertainment (CZR) to Post Q2 Earnings: What's in Store? https://www.zacks.com/stock/news/2311202/caesars-entertainment-czr-to-post-q2-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311202 Jul 29, 2024 - Increased competition, construction disruptions and higher expenses are likely to have affected Caesars Entertainment's (CZR) Q2 performance.
Gildan Activewear (GIL) to Post Q2 Earnings: Factors to Note https://www.zacks.com/stock/news/2311061/gildan-activewear-gil-to-post-q2-earnings-factors-to-note?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311061 Jul 29, 2024 - Gildan Activewear's (GIL) concentrated efforts on key product lines, particularly in the activewear segment, are expected to have contributed to top-line growth in the second quarter.
Janus Henderson (JHG) to Post Q2 Earnings: What's in Store? https://www.zacks.com/stock/news/2311110/janus-henderson-jhg-to-post-q2-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311110 Jul 29, 2024 - Janus Henderson's (JHG) second-quarter 2024 results are likely to benefit from favorable equity market performance. Yet, a rise in costs is likely to be a spoilsport.
What Awaits Biogen (BIIB) in Q2 Earnings Post Leqembi Setback? https://www.zacks.com/stock/news/2311049/what-awaits-biogen-biib-in-q2-earnings-post-leqembi-setback?cid=CS-ZC-FT-analyst_blog|earnings_preview-2311049 Jul 29, 2024 - Biogen's (BIIB) sales in the second quarter are likely to have been hurt by lower sales of its multiple sclerosis drugs, while sales of Spinraza are likely to have been hurt by increased competition.
AT&T: Moving To A Hold Post Q2 2024 Results https://seekingalpha.com/article/4707517-att-moving-to-hold-post-q2-2024-results?source=feed_all_articles Jul 28, 2024 - Financial analysis of AT&T: Q2-2024 results were positive, but we have moved to a Hold rating.
Zebra Technologies (ZBRA) to Post Q2 Earnings: What to Expect https://www.zacks.com/stock/news/2310289/zebra-technologies-zbra-to-post-q2-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310289 Jul 26, 2024 - Zebra Technologies' (ZBRA) Q2 results are likely to benefit from the solid demand for services, software and RFID products. Weakness in the printing end market is likely to hurt its results.
Newell's (NWL) Q2 Earnings Beat Mark, Soft Core Sales Hurt https://www.zacks.com/stock/news/2310288/newell-s-nwl-q2-earnings-beat-mark-soft-core-sales-hurt?cid=CS-ZC-FT-analyst_blog|earnings_article-2310288 Jul 26, 2024 - Newell (NWL) reports a sales decline in second-quarter 2024, owing to a core sales drop of 4.2% year over year.
Xylem (XYL) Gears Up to Post Q2 Earnings: What to Expect https://www.zacks.com/stock/news/2310281/xylem-xyl-gears-up-to-post-q2-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310281 Jul 26, 2024 - Xylem's (XYL) second-quarter 2024 results are likely to gain from strength across its smart metering and other applications end markets despite weakness in the building solutions end market.
Match Group (MTCH) to Post Q2 Earnings: What's in Store? https://www.zacks.com/stock/news/2310269/match-group-mtch-to-post-q2-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310269 Jul 26, 2024 - Match Group's (MTCH) second-quarter results will likely reflect strength in Tinder, Hinge and Azar. However, weakening demand in the United States might have been a concern.
IPG Photonics (IPGP) to Post Q2 Earnings: What's in the Cards? https://www.zacks.com/stock/news/2310274/ipg-photonics-ipgp-to-post-q2-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2310274 Jul 26, 2024 - IPG Photonics' (IPGP) second-quarter 2024 results are likely to suffer from weakness in cutting and marking applications and continued economic uncertainty.

Pages: 1...1415161718192021222324...61

<<<Page 19>